Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · IEX Real-Time Price · USD
7.09
+0.04 (0.57%)
At close: Apr 26, 2024, 4:00 PM
6.77
-0.32 (-4.51%)
After-hours: Apr 26, 2024, 6:05 PM EDT
Titan Pharmaceuticals Revenue
In the year 2023, Titan Pharmaceuticals had annual revenue of $184.00K, a decrease of -66.97%.
Revenue (ttm)
$184.00K
Revenue Growth
-66.97%
P/S Ratio
35.23
Revenue / Employee
$46,000
Employees
4
Market Cap
6.48M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 184.00K | -373.00K | -66.97% |
Dec 31, 2022 | 557.00K | -969.00K | -63.50% |
Dec 31, 2021 | 1.53M | -3.31M | -68.46% |
Dec 31, 2020 | 4.84M | 2.23M | 85.72% |
Dec 31, 2019 | 2.61M | -4.01M | -60.64% |
Dec 31, 2018 | 6.62M | 6.40M | 2,978.14% |
Dec 31, 2017 | 215.00K | -14.85M | -98.57% |
Dec 31, 2016 | 15.07M | 13.39M | 801.56% |
Dec 31, 2015 | 1.67M | -1.98M | -54.17% |
Dec 31, 2014 | 3.65M | -6.84M | -65.21% |
Dec 31, 2013 | 10.48M | 3.36M | 47.27% |
Dec 31, 2012 | 7.12M | 3.05M | 74.95% |
Dec 31, 2011 | 4.07M | -6.03M | -59.69% |
Dec 31, 2010 | 10.09M | 10.01M | 12,675.95% |
Dec 31, 2009 | 79.00K | 6.00K | 8.22% |
Dec 31, 2008 | 73.00K | 49.00K | 204.17% |
Dec 31, 2007 | 24.00K | -8.00K | -25.00% |
Dec 31, 2006 | 32.00K | -57.00K | -64.04% |
Dec 31, 2005 | 89.00K | 58.00K | 187.10% |
Dec 31, 2004 | 31.00K | -58.00K | -65.17% |
Dec 31, 2003 | 89.00K | -2.80M | -96.92% |
Dec 31, 2002 | 2.89M | -1.68M | -36.75% |
Dec 31, 2001 | 4.57M | 2.69M | 143.19% |
Dec 31, 2000 | 1.88M | 1.54M | 457.86% |
Dec 31, 1999 | 337.00K | - | - |
Dec 31, 1998 | 0 | - | - |
Dec 31, 1997 | 17.50M | 17.24M | 6,661.67% |
Dec 31, 1996 | 258.81K | 119.29K | 85.50% |
Dec 31, 1995 | 139.52K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Avinger | 7.65M |
Kineta | 5.44M |
OpGen | 3.07M |
Xenetic Biosciences | 2.54M |
Azitra | 686.00K |
Heart Test Laboratories | 18.60K |
TTNP News
- 3 months ago - Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria - GlobeNewsWire
- 4 months ago - Titan Pharmaceuticals Announces Reverse Stock Split and Ratio - GlobeNewsWire
- 6 months ago - Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors - GlobeNewsWire
- 7 months ago - Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock - GlobeNewsWire
- 9 months ago - Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Provides Shareholder Update - GlobeNewsWire
- 1 year ago - UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc. - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces Board Expansion and Management Changes - PRNewsWire